Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 10;24(12):3772.
doi: 10.3390/s24123772.

Utilizing COVID-19 as a Model for Diagnostics Using an Electrochemical Sensor

Affiliations

Utilizing COVID-19 as a Model for Diagnostics Using an Electrochemical Sensor

Ava Gevaerd et al. Sensors (Basel). .

Abstract

This paper reports a rapid and sensitive sensor for the detection and quantification of the COVID-19 N-protein (N-PROT) via an electrochemical mechanism. Single-frequency electrochemical impedance spectroscopy was used as a transduction method for real-time measurement of the N-PROT in an immunosensor system based on gold-conjugate-modified carbon screen-printed electrodes (Cov-Ag-SPE). The system presents high selectivity attained through an optimal stimulation signal composed of a 0.0 V DC potential and 10 mV RMS-1 AC signal at 100 Hz over 300 s. The Cov-Ag-SPE showed a log response toward N-PROT detection at concentrations from 1.0 ng mL-1 to 10.0 μg mL-1, with a 0.977 correlation coefficient for the phase (θ) variation. An ML-based approach could be created using some aspects observed from the positive and negative samples; hence, it was possible to classify 252 samples, reaching 83.0, 96.2 and 91.3% sensitivity, specificity, and accuracy, respectively, with confidence intervals (CI) ranging from 73.0 to 100.0%. Because impedance spectroscopy measurements can be performed with low-cost portable instruments, the immunosensor proposed here can be applied in point-of-care diagnostics for mass testing, even in places with limited resources, as an alternative to the common diagnostics methods.

Keywords: SARS-CoV-2; electrochemical sensor; nucleocapsid protein; point-of-care test; screen-printed electrodes.

PubMed Disclaimer

Conflict of interest statement

Marcus V.M. Figueredo is the CEO of Hilab; Sérgio Rogal-Junior is the CTO of Hilab; Diego R.P. Nicollete is R&D manager at Hilab; Ava Gevaerd is electrochemical manager at Hilab; Emmanuelle A. Carneiro and Jeferson L. Gogola are health researchers at Hilab; Luis F. Hartmann is head of R&D at Hilab; João V. Predebon and Adriano Timm are R&D researchers at Hilab; Carlos Rochitti is a researcher at PUC University; Gustavo L. Marques and Maira M.O.N. Loesch are assistant doctors at Marcelino Champagnat Hospital; Bernardo M.M. de Almeida is medical director at Hilab. Other remaining authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Hilab Volt. (B) COVID-19 sample collection and analysis procedure.
Figure 2
Figure 2
Proposed COVID-19 diagnostics principle for the CovAg-SPE sensor analyzing negative and positive nasopharyngeal swab samples, and the parameters influencing the input and output signals.
Figure 3
Figure 3
(A) Electrochemical calibration curve for N−protein detection in spiked negative nasopharyngeal swab samples (n = 3). (B) Schematic representation of the superficial interactions and capacitors formed by the recognized layer and the analyte layer. t = 300 s; f = 100 Hz; EAC = 0.01 V; EDC = 0 V; electrolyte: 0.01 M 7.4−PB.
Figure 4
Figure 4
Positive and negative sample behavior as a time function for (A) imaginary impedance, and (B) phase. (C) Characteristic behavior used for classification of real samples in validation. (D) Bar graph constructed from the concomitant species study. t = 300 s; f = 100 Hz; EAC = 0.01 V; EDC = 0 V; electrolyte: 0.01M 7.4-PB.

Similar articles

References

    1. Qazi S., Raza K. Smart Biosensors in Medical Care. Elsevier Inc.; Amsterdam, The Netherlands: 2020. Smart Biosensors for an Efficient Point of Care (PoC) Health Management; pp. 65–85.
    1. Kelly-Cirino C.D., Nkengasong J., Kettler H., Tongio I., Gay-Andrieu F., Escadafal C., Piot P., Peeling R.W., Gadde R., Boehme C. Importance of Diagnostics in Epidemic and Pandemic Preparedness. BMJ Glob. Health. 2019;4:e001179. doi: 10.1136/bmjgh-2018-001179. - DOI - PMC - PubMed
    1. Gao X., Yang D., Yuan Z., Zhang Y., Li H., Gao P., Liu X., Zhao W., Xiao T., Guan Y., et al. Improving the Early Diagnosis of Suspected Patients with COVID-19: A Retrospective Study of 106 Patients. J. Infect. Dev. Ctries. 2020;14:547. doi: 10.3855/jidc.12992. - DOI - PubMed
    1. Tertis M., Hosu O., Florea A., Cristea C. Immunodiagnostic Technologies from Laboratory to Point-of-Care Testing. Springer; Singapore: 2021. Biosensors for Clinical Samples: Consideration and Approaches; pp. 1–32.
    1. Wang Y., Xu H., Zhang J., Li G. Electrochemical Sensors for Clinic Analysis. Sensors. 2008;8:2043. doi: 10.3390/s8042043. - DOI - PMC - PubMed

MeSH terms